z-logo
open-access-imgOpen Access
Cytokine Autoantibody Screening in the Swedish Addison Registry Identifies Patients With Undiagnosed APS1
Author(s) -
Daniel Eriksson,
Frida Dalin,
Gabriel Nordling Eriksson,
Nils Landegren,
Matteo Bianchi,
Åsa Hallgren,
Per Dahlqvist,
Jeanette Wahlberg,
Olov Ekwall,
Ola Winqvist,
SergiuBogdan Catrina,
Johan Rönnelid,
AnnaLena Hulting,
Kerstin LindbladToh,
Mohammad Alimohammadi,
Eystein S. Husebye,
Per M. Knappskog,
Gerli Pielberg,
Sophie Bensing,
Olle Kämpe,
Tommy Olsson,
Berit Kriström,
Maria Laudius,
Magnus Isaksson,
Maria Halldin Stenlid,
Jan Gustafsson,
Gennet GebreMedhin,
Sigríður Björnsdóttir,
G. Eriksson,
Annika Janson,
AnnaKarin Åkerman,
Ragnhildur Bergthorsdottir,
Gudmundur Johannsson,
Emma Lindskog,
Maria Elfving,
Erik Waldenström,
Johan Svensson,
Zlatka Kalcheva,
Mats Eliasson,
Erik Hedman,
Karin Wahlin,
Anders Magnusson,
Bertil Ekman,
Karel Duchen Munoz
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01957
Subject(s) - autoantibody , medicine , addison's disease , immunology , antibody , disease
Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features autoimmune Addison disease as a major component. Although APS1 accounts for only a small fraction of all patients with Addison disease, early identification of these individuals is vital to prevent the potentially lethal complications of APS1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom